Mammographic density changes during neoadjuvant breast cancer treatment: NeoDense, a prospective study in Sweden
Objectives: To assess if mammographic density (MD) changes during neoadjuvant breast cancer treatment and is predictive of a pathological complete response (pCR). Methods: We prospectively included 200 breast cancer patients assigned to neoadjuvant chemotherapy (NACT) in the NeoDense study (2014–201...
Main Authors: | Ida Skarping, Daniel Förnvik, Uffe Heide-Jørgensen, Hanna Sartor, Per Hall, Sophia Zackrisson, Signe Borgquist |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-10-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S096097762030120X |
Similar Items
-
Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer
by: Ida Skarping, et al.
Published: (2019-12-01) -
Are baseline ultrasound and mammographic features associated with rates of pathological completes response in patients receiving neoadjuvant chemotherapy for breast cancer?
by: Sarah L. Savaridas, et al.
Published: (2019-10-01) -
the Ultrasound Findings of Mammographically Dense Breasts in A Sample of Iraqi Female Patients
by: khaleel Mohson
Published: (2019-07-01) -
Relationship of mammographic densities to breast cancer risk
by: Engy A. Ali, et al.
Published: (2021-05-01) -
Mammographic and ultrasonographic findings of different breast adenosis lesions
by: E Ozturk, et al.
Published: (2015-09-01)